Compass Pathways PLC
NASDAQ:CMPS
Compass Pathways PLC
EPS (Diluted)
Compass Pathways PLC
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Compass Pathways PLC
NASDAQ:CMPS
|
EPS (Diluted)
-$2
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
EPS (Diluted)
-$1
|
CAGR 3-Years
-136%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
EPS (Diluted)
-$1
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
EPS (Diluted)
-$3
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
EPS (Diluted)
-£1
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
EPS (Diluted)
£0
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
See Also
What is Compass Pathways PLC's EPS (Diluted)?
EPS (Diluted)
-2.3
USD
Based on the financial report for Dec 31, 2023, Compass Pathways PLC's EPS (Diluted) amounts to -2.3 USD.
What is Compass Pathways PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-42%
Over the last year, the EPS (Diluted) growth was -7%. The average annual EPS (Diluted) growth rates for Compass Pathways PLC have been -11% over the past three years , -42% over the past five years .